The piggyBac (PB) transposon is one of the most useful transposable elements, and has been successfully used for genetic manipulation in more than a dozen species. However, the efficiency of PB-mediated transposition is still insufficient for many purposes. Here, we present a strategy to enhance transposition efficiency using a fusion of transcription activator-like effector (TALE) and the PB transposase (PBase). The results demonstrate that the TALE-PBase fusion protein which is engineered in this study can produce a significantly improved stable transposition efficiency of up to 63.9%, which is at least 7 times higher than the current transposition efficiency in silkworm. Moreover, the average number of transgene-positive individuals increased up to 5.7-fold, with each positive brood containing an average of 18.1 transgenic silkworms. Finally, we demonstrate that TALE-PBase fusion-mediated PB transposition presents a new insertional preference compared with original insertional preference. This method shows a great potential and value for insertional therapy of many genetic diseases. In conclusion, this new and powerful transposition technology will efficiently promote genetic manipulation studies in both invertebrates and vertebrates.
The piggyBac (PB) transposon is one of the most useful transposable elements, and has been successfully used for genetic manipulation in more than a dozen species. However, the efficiency of PB-mediated transposition is still insufficient for many purposes. Here, we present a strategy to enhance transposition efficiency using a fusion of transcription activator-like effector (TALE) and the PB transposase (PBase). The results demonstrate that the TALE-PBase fusion protein which is engineered in this study can produce a significantly improved stable transposition efficiency of up to 63.9%, which is at least 7 times higher than the current transposition efficiency in silkworm. Moreover, the average number of transgene-positive individuals increased up to 5.7-fold, with each positive brood containing an average of 18.1 transgenic silkworms. Finally, we demonstrate that TALE-PBase fusion-mediated PB transposition presents a new insertional preference compared with original insertional preference. This method shows a great potential and value for insertional therapy of many genetic diseases. In conclusion, this new and powerful transposition technology will efficiently promote genetic manipulation studies in both invertebrates and vertebrates.
Transcription activator-like effectors (TALEs) are naturally conserved bacterial effector
proteins derived from the Xanthomonas genus of plant pathogenic bacteria1. To date, TALE proteins have been described as having a simple modular
DNA recognition code23, that is composed of repeat domains of
33–35 amino acids. The specificity of TALE is determined by the
repeat-variable di-residues (RVDs) at positions 12 and 13 of these repeats45. In recent years, TALE nucleases (TALENs) have been successfully and
widely used for the targeted editing of endogenous genes in various species, including
yeast6, nematodes7, frogs8,
insects910, fish11121314, plants1516 and mammals1718. TALE proteins have also been
engineered with transcriptional regulatory domains to generate artificial transcription
factors that can regulate the expression of targeted endogenous genes1619202122232425. Recent, studies have demonstrated that
TALEs can be efficiently exploited to modify epigenomes in a targeted manner262728.The piggyBac (PB) transposon, which was originally isolated from the genome
of the cabbage looper moth Trichoplusia ni29, is a type of
non-viral vector characterized by a large cargo size30, low toxicity31 and long-term expression3233. PB
transposon-mediated gene transfer has been successfully performed in various organisms,
both invertebrates and vertebrates. Studies in silkworm have benefited from this
technology because the silk-gland bioreactor shows great potential for the production of
vast quantities of valuable exogenous protein via PB-mediated transgenesis. The
PB transposon system is undoubtedly a powerful genetic manipulation tool for
transgenesis and insertional mutagenesis and is currently being applied to the
development of a new generation vector for research in human gene therapy and induced
pluripotent stem cells343536. However, the efficiency of
PB-mediated transposition remains limited and unstable. The earliest and most
appropriate method for evaluating transposition efficiency in silkworm is to calculate
the percentage of G1 positive broods among all G0 moths37. Using this
method, we have collected and analyzed most of the published transgenic data. However,
as the current average for transposition efficiency in silkworm is 8.8% (Supplementary Table S1). The present transposition
level must be improved to satisfy the requirements of research and to further promote
the application of the PB system.This study presents a monomeric fusion protein engineered from TALE repeat arrays and
PB transposase (PBase) to further exploit the potential functions of
TALE. We find that the TALE-PBase fusion protein can significantly improve the
transposition efficiency of the PB system.
Results
Transposition efficiency of piggyBac in silkworm
To investigate whether a programmable TALE could improve transposition
efficiency, three types of plasmids were constructed: pESNT-PBase,
consisting of EF1α and SP6 promoters, a nuclear localization signal
(NLS), a TALE repeat domain targeting first exon of the fibroin
light-chain gene and PBase (Fig. 1a);
pESN-PBase, with the TALE sequence deleted (Fig.
1b); and pES-PBase, with both NLS and TALE sequence deleted
(Fig. 1c). These plasmids were then transcribed in
vitro to obtain mRNAs and each mRNA was mixed with the
pB3 × P3EGFP transposon plasmid (Fig. 1d) and microinjected into fertilized embryos of the
P50 silkworm strain. All of the positive silkworms exhibited a
similar phenotype of larvae with green ocelli or moths with green compound eyes
(Fig. 2a–h). To identify the optimal
microinjection dose, four different concentrations of pESNT-PBase mRNA
(Table 1) were injected. The hatching rate of the
microinjected embryos decreased significantly with increasing concentration of
pESNT-PBase mRNA (Table 1, Fig. 3a); the highest concentration
(400 ng/μL) induced a high embryonic death rate, and
only 3.0% of microinjected embryos hatched normally (Table
1). However, neither the highest or lowest mRNA concentration could
result in the best transposition efficiency. Overall, injected of
200 ng/μL produced the best transposition efficiency,
63.8% (37/58), which was significantly higher than with the other concentrations
(Table 1, Fig. 3b). Using this
optimal concentration, we compared the transposition efficiencies of three
different plasmids, pESNT-PBase, pESN-PBase and pES-PBase.
PBase fused to the NLS (pESN-PBase) did not significantly
improve the transposition efficiency in comparison with PBase alone
(pES-PBase, P > 0.05) (Table 1, Fig. 3c). In contrast, the
transformation frequency was significantly
(P < 0.01) improved up to 63.9% (23/36)
when pESNT-PBase, containing the TALE domain, was injected (Table 1, Fig. 3c). These data
demonstrate that the TALE domain robustly improve transposition efficiency.
Figure 1
Design and construction of artificial TALE and PB transposon plasmids
for producing transgenic silkworms.
(a) Schematic representation of the TALE tandem repeat domain and each
repeat monomer, including the two repeat variable di-residues (RVD) at
positions 12 and 13 of each amino acid sequence, which determine the base
recognition specificity. TALE arrays comprising 16 repeats (colored ovals)
fused to the PB transposase (PBase). EF1α,
elongation factor-1 alpha promoter; SP6, a prokaryotic promoter used for
high-efficiency mRNA transcription in vitro; NLS, nuclear
localization signal; Fib-L gene, fibroin light-chain gene of
silkworm; TSS, transcriptional start site; TTAA, the target insertion site
of the PB transposon. (b) Schematic representation of the TALE
repeats are deleted in the pESN-PBase plasmid based on the
pESNT-PBase plasmid. (c) Both the TALE repeat and the NLS
are deleted in the pES-PBase plasmid. (d,e) Diagram of
the structure of PB transposon plasmids. ITR, inverted terminal
repeats of the PB transposon;
3 × P3 promoter, an artificial promoter
specifically driving reporter gene expression in the ocelli of larvae or
compound eyes of moths; FL promoter, silkworm fibroin light-chain
promoter; HSA, human serum albumin.
Figure 2
Fluorescence of EGFP or DsRed is specific in the eyes of transgenic
silkworm.
The first and third columns are viewed under the excitation wavelengths of
GFP and DsRed, respectively; the second and fourth columns are white light
illumination. The first and third rows are wild-type (WT) larvae on the
first day after hatching and moths, respectively; the second and fourth rows
are transgenic larvae on the first day after hatching and moths,
respectively.
Table 1
TALE-mediated piggyBac transposition efficiency in P50
strain.
Transgenic strain
Injected mRNA/concentration
(ng/μL)
Microinjected embryos
Hatched embryos (%)
G1 generation broods
Examined G1 broods
EGFP-positive G1 broods (From examined
broods)
Percentage of transposition efficiency (%)
ESNT-PB-75
pESNT-PBase/75
770
192 (24.9)
89
47
3
6.4
ESNT-PB-150
pESNT-PBase/150
1100
227 (20.6)
83
56
18
32.1
ESNT-PB-200a
pESNT-PBase/200
850
71 (8.4)
58
58
37
63.8
ESNT-PB-400
pESNT-PBase/400
1450
44 (3.0)
17
17
5
29.4
ESNT-PB-200b
pESNT-PBase/200
900
75 (8.3)
36
36
23
63.9
ESN-PB-200
pESN-PBase/200
900
203 (22.6)
110
48
8
16.7
ES-PB-200
pES-PBase/200
800
93 (11.6)
119
51
7
13.7
The microinjected PB transposon plasmid was
pB3 × P3EGFP and the
concentration was 300 ng/μL.
Figure 3
Statistical analysis of the embryos hatching rate and transposition
efficiency.
(a) The hatching rate is directly related to the concentration of
pESNT-PBase mRNA injected. The hatching rate was significantly
reduced by increasing the microinjection concentration. (b)
Statistical analysis of the transposition efficiency indicates that
200 ng/μL of pESNT-PBase mRNA is the optimal
concentration for obtaining the highest transposition efficiency and a
moderate hatching rate (ESNT-PB-200a series transgenic strains).
(c,d) The TALE-PBase fusion can significantly
enhance the transposition frequency and maintain transposition at a high
level (ESNT-PB-200a, ESNT-PB-200b and ESNT-PB-HSA), even using a larger
PB transposon plasmid and in a new silkworm strain.
*P < 0.05,
**P < 0.01, using a significance test
for percentage of two samples.
To demonstrate the universality of pESNT-PBase-mediated high-efficiency
transposition, we selected a different silkworm strain, Lan10, as the
transgenic receptor and constructed a larger PB transposon as the donorplasmid (Fig. 1e). The reporter gene
3 × P3DsRed was specifically expressed in
the eyes of all positive transgenic silkworms (Fig.
2i–p). Indeed, pESNT-PBase significantly
(P < 0.01) improved transposition
efficiency, reaching 54.4% (56/103) in ESNT-PB-HSA series transgenic strains
compared with PB-HSA strains (18.1%, 21/116) and producing significantly
(P < 0.01) higher transposition rates
than the ESN-PB-200 (16.7%, 8/48) and ES-PB-200 (13.7%, 7/51) transgenic strains
(Table 2, Fig. 3d). However,
the transposition efficiency of ESNT-PB-HSA series transgenic strains was not
significantly different from that of ESNT-PB-200a. These data again confirmed
that the TALE-PBase fusion could significantly and stably increase
transposition frequency, even with a larger cargo size of the transposon plasmid
and in a different silkworm strain.
Table 2
TALE-mediated piggyBac transposition efficiency in Lan10
strain.
Transgenic strain
Injected mRNA or DNA/concentration
(ng/μL)
Microinjected embryos
Hatched embryos (%)
G1 generation examined broods
DsRed -positive G1 broods
Percentage of transposition efficiency (%)
ESNT-PB-HSA
pESNT-PBase/200
1100
234 (21.3)
103
56
54.4
PB-HSA
PBase (DNA)/200
1100
258 (23.4)
116
21
18.1
The microinjected PB transposon plasmid was
pB3 × P3DsRed-FLHSA and
the concentration was 200 ng/μL.
Furthermore, we compared the numbers of transgenic-silkworms in positive broods
among ESNT-PB-HSA, PB-HSA, ESN-PB-200 and ES-PB-200. The average number of
positive individuals in each ESNT-PB-HSA series transgenic brood reached 18.1,
which was 1.5–5.7 times higher than for the three controls (Fig. 4a). We further performed a more detailed statistical
analysis of the number of transgene-positive individuals between ESNT-PB-HSA and
PB-HSA. The proportion of broods with more than 20 positive individuals, and
especially with more than 30, was dramatically improved in ESNT-PB-HSA (Fig. 4b,c), for which nearly a quarter of positive broods
were identified as containing over 30 transgene-positive silkworms. One positive
brood (the ESNT-PB-HSA49 transgenic strain) contained 92 transgenic individuals
(Supplementary Table S2). In
general, TALE-mediated high-efficiency transposition is reflected in both the
number of positive broods and the number of transgenic individuals per positive
brood.
Figure 4
Quantification of transgenic individuals in each brood.
(a) The average number of positive silkworms in the ESNT-PB-HSA series
transgenic strain was 5.7, 4.5 and 1.5 times higher than in ES-PB-200,
ESN-PB-200 and PB-HSA, respectively. (b,c) Total positive
broods are divided into four groups to more clearly present the distribution
of the number of transgenic individuals in each brood. The pie charts show
that the proportions of broods with 21–30
and > 30 transgenic individuals were
dramatically improved in the ESNT-PB-HSA series transgenic silkworms
compared with PB-HSA.
Analysis of insertion sites
Previous studies have demonstrated that native PBase-mediated gene
transposition primarily occurs at TTAA sites and has an insertional preference
for AT-rich regions with 5 Ts before and 5 As after the TTAA sites in both
insect and mammal3839. Our analysis of integration sites
indicated that all insertion events occurred in TTAA sites, which were widely
distributed among the chromosomes (Fig. 5a, Supplementary Table S3). Most of the
transposition events occurred in introns and intergenic regions, with only 7.0%
occurring in exons (Fig. 5b). Moreover, a sequence logo
analysis indicated that the majority of insertion sites occurred in AT-rich
regions (Fig. 5c). However, it is noteworthy that the
proximal ten bases around the TTAA site presented a new pattern: the proportions
of C, A and G bases at position −5, −3 and+5,
respectively, were significantly enriched in comparison with previous studies
(Fig. 5c). We believe that the insertional preference
of PB was substantially altered by using the TALE-PBase fusion
protein. In theory, the TALE-PBase fusion could achieve site-specific
integration; however, no insertion events have been identified as occurring in a
targeted manner. In the present study, two transposition events, ESNT-PB-200a26
and ESNT-PB-200b18, were identified integrating in the target chromosome
(chromosome 14) and scaffold (scaffold 81) (Supplementary Table S3), but which were
278,440 bp and 156,461 bp away from the target
integration site, respectively.
Figure 5
piggyBac insertion site analysis in silkworm.
(a) Distribution of PB integration sites on chromosomes.
PB broadly targeted all chromosomes, except chromosomes10 and 27.
(b) Analysis of integration sites in genes showing that most
PB insertions were found in intergenic regions and introns, with
only 7.0% appearing in exons. (c) Sequence logo analysis of the
nucleotide composition of 20 bp flanking sequences around the
insertion site “TTAA” based on 71 PB
insertion events. All of the integrations show TTAA target site specificity,
and an enrichment of As and Ts in the flanking sequences is observed.
However, the nearest five nucleotides upstream and downstream of the
integration sites are changed, presenting a novel pattern of nucleotide
composition compared with previous reports.
Discussion
The extensive utilization of the PB transgenic system has been proven its
value in genetic manipulation studies. In recent years, TALEs have demonstrated
powerful functions in targeted gene editing, gene regulation and locus-specific
histone modifications. So far, no reports have been found from available literatures
about the TALE-PBase fusions can improve transposition efficiency in other
species. The purpose of the present study was to engineer a TALE-PBase fusion
to improve transposition efficiency. Our results show that PBase fused to an
NLS cannot significantly enhance transposition efficiency, suggesting that
PBase may already contain a functional nuclear targeting signal40. Therefore, TALE was the most important factor that improved
PB transposition efficiency, which was enhanced by almost 64%, at least 7
times higher than the current average transposition efficiency in silkworm. In
addition, the number of positive individuals in each transgenic brood was maximally
increased by up to 5.7-fold. The improvements in these two characteristics present a
breakthrough in the optimization of the PB transposon system. Moreover,
modestly increasing the PB cargo size did not produce a significant reduction
(P > 0.05) in the transposition
efficiency. Thus, a PB element can simultaneously carry multiple genes to
satisfy complex transgenic studies without reducing the frequency of transposition.
The PB-mediated transgenic efficiency is affected by many factors, so it is
hard to get a generally stable transgenic efficiency in the previous studies. In
general, the transgenic efficiency of PB is insufficient in silkworms. From
Supplementary Table S1 we could find
that only one study achieved high-efficiency transgenesis (57.61%), but such a
result was unstable, which merely appeared once from the four independent transgenic
experiments41. In our study, the sufficient data demonstrate that
the high transgenic efficiency is more stable and repeatable instead of appearing as
an accidental phenomenon. So, our results fully illustrate the reliability of the
TALE mediates high-efficiency transposition. The native PBase may be replaced
by this new-type and high-efficient TALE-PBase fusion in the future. The next
step of the research is to construct more TALE-PBase fusion proteins with
different targets, which may help us to find more efficient TALE-PBase
fusions.This high TALE-mediated transposition frequency may be induced by multiple factors.
The fusion of TALE and PBase may increase the three-dimensional structural
stability of PBase, possibly prolonging the period of enzyme activity. As a
result, more PB transposons are efficiently inserted into the genome.
Furthermore, although the gene regulation is complex, it can be accurately
long-range controlled by distant regulatory elements, including enhancers and
repressors, to coordinated expression of genes in the third dimension4243. TALE-mediated gene transposition may also be achieved in a
long-range manner in the third dimension (Supplementary Fig. S1). In our study, a monomer TALE was fused to an
intact PBase, producing an enzyme that can perform all the steps necessary
for transposition. We therefore reason that the TALE-PBase fusion will
combine with many potential candidate loci that may not perfectly matched the
preferred TALE site. When TALE recognizes an appropriate site in the genome,
PBase will execute transposition at multiple candidate
“TTAA” sites (Supplementary Fig. S1) because the TALE-PBase fusion protein is
larger than the native PBase protein and thus can perform transposition at a
larger spatial scale. As some candidate “TTAA” sites may be
hundreds of kilobases away from the TALE binding site (Supplementary Fig. S1a) or may even be located on
different chromosomes (Supplementary Fig.
S1b), the three-dimensionality of TALE-mediated transposition contributes
to improving transposition efficiency.Using a PBase coupled with a TALE, the first site-specific insertion of
PB was recently identified in ~0.010-0.014% of stably
transfected human cells44. Although this demonstrates that targeted
insertions can be achieved, but the efficiency is still very low. Here, we have not
found site-specific integration events, but TALE-mediated transposition has been
shown to slightly alter the original insertion preference of PB (Fig. 5c). So, site-specific integration is still a challenge,
but it may be markedly improved if the ability of PBase to recognize its
target locus is weakened without compromising its catalytic function. Our results
provide important clues for developing a high-efficiency insertional therapy tool
which has shown greatly potential value in genetic disease therapy.In summary, our study first demonstrates that the TALE-PBase fusion powerfully
improves transposition efficiency in silkworms. This discovery introduces a new area
for the application of TALE in research. To date, the PB system and TALE have
been widely applied in various species of invertebrates and vertebrates. Thus, we
believe that a TALE-PBase fusion will also function well in organisms other
than silkworms. Our study will greatly promote PB-mediated genetic
manipulation studies, including the generation of transgenic animals, insertional
mutagenesis and gene therapy.
Methods
Construction of TALE-PBase fusion and transgenic
plasmids
Target TALE assembly was performed using a FastTALETM TALEN kit
(SIDANSAI biotechnology CO., LTD) according to the manufacturer’s
instructions. The targeted binding site was in the first exon of the fibroin
light chain (Fib-L) gene (chromosome14, scaffold81) (Supplementary Fig. S2), the
expression product of which is the main component of fibroin in silkworm. The
PBase gene was then engineered into the TALE vector, and the
constructed plasmid was named pESNT-PBase due to the inclusion of
EF1α, a ubiquitous promoter which exhibits a strong activity in
eukaryotic cells, and SP6 promoters, an NLS, a TALE repeat domain and
PBase. In addition, two control plasmids, pESN-PBase (TALE
deleted) and pES-PBase (both TALE and NLS deleted), were constructed from
pESNT-PBase. The mRNA of these vectors was synthesized in
vitro using an SP6 mMESSAGE mMACHINE Kit (Ambion). The donor plasmids
pB3 × P3EGFP and
pB3 × P3DsRed-FLHSA (FLHSA, human serum
albumin gene driven by a Fib-L promoter) were constructed based on
pBA3EGFP transposon plasmid. The marker gene (EGFP or DsRed) was controlled by a
3 × P3 promoter, an artificial promoter
specifically driving expression in the eyes and nervous tissues, which is useful
for the screening of positive individuals. All plasmids were extracted using the
Quick Plasmids Miniprep kit (Invitrogen), followed by further purification to
remove residual RNase A, as described in the SP6 mMESSAGE mMACHINE Kit (Ambion).
Briefly, plasmid DNA was treated with 0.5% SDS and proteinase K
(200 μg/mL) for 30 min at
50 °C, followed by phenol/chloroform extraction (using
an equal volume) and precipitation with 2 volumes of ethanol. Finally, the
samples were centrifuged at 23,500 g for 15 min
to harvest the purified DNA.
Transgenesis and screening of silkworms
The experimental animals P50 (Dazao) and Lan10, multivoltine
silkworm strains with diapause ability, were reared on fresh mulberry leaves
under standard conditions (25 °C, 80% R.H). Embryo
microinjection and the screening of positive silkworms were performed as
described previously3745. Briefly, zygotes were collected
promptly, and microinjection was completed within 4 h after
oviposition. The helper plasmid pESNT-PBase mRNA was mixed with the donorplasmid pB3 × P3EGFP based on the actual
concentration before injection into one-cell-stage fertilized eggs. The
microinjected eggs were cultured under standard conditions, and each surviving
moth was mated with wild-type moths to obtain G1 generations. Finally, positive
individuals were screened from G1 broods based on the presence of green or red
eyes using a fluorescence microscope SZX16 (Olympus). The procedures for the
other two helper plasmid mRNAs, pESN-PBase and pES-PBase, were
similar to the protocol described above.
Statistics of published transposition efficiency
The most appropriate method for the evaluation of silkworm transposition
efficiency is to calculating the percentage of G1 positive broods in total G0
moths37. However, in some studies, transgenic G0 moths were
mated with each other or mated within the same family to generate G1 broods, and
the ratio of G1 positive broods/total G1 broods was calculated as the final
transposition efficiency. This computation method led to transposition
efficiencies that were nearly twice those obtained using the former method.
Therefore, we calibrated these transposition efficiencies by halving them in an
effort to standardize the method for computing transposition efficiency.Inverse PCR analysis37 was conducted after genomic DNA was
isolated from each positive transgenic silkworm strain. Briefly, 1
μg of total genomic DNA was digested with Sau3A I at
37 °C for 2 h and then self-ligated
overnight at 16 °C using T4 DNA ligase (TAKARA). A
25–50 ng sample of ligated products were amplified using
EX Taq polymerase (TAKARA) and specific primers
(pB3 × P3EGFP left arm primer pair,
5′-ATCAGTGACACTTACCGCATTGACA-3′ and
5′-TGACGAGCTTGTTGGTGAGGATTCT-3′;
pB3 × P3EGFP right arm primer pair,
5′-TACGCATGATTATCTTTAACGTA-3′ and
5′-GGGGTCCGTCAAAACAAAACATC-3′). The PCR program was
conducted with a 3 min denaturation cycle at
96 °C followed by 40 cycles of 30 s at
96 °C, 30 s at
60 °C, and 2 min at
72 °C, and a final extension at
72 °C for 10 min. The amplified PCR products
were sequenced after cloning in pMD19-T (TAKARA) to identify the exact sites of
PB insertion into silkworm chromosomes. Two pairs of primers were
designed for PCR detection of the same insertion sites. The forward primer
5′-CCTGTGGTAGATTCTGCGAAG-3′ and the reverse primer
5′-CCTTTACATGAGCCTGACGTCA-3′ were used for
identification of ESNT-PB-200a1 and ESNT-PB-200a17a transgenic strains; the
forward primer 5′-TCTGTCGCAAGTCGCCAGTTT-3′ and reverse
primer 5′-CCTTTACATGAGCCTGACGTCA-3′ were used for the
identification of ESNT-PB-200a31 and ESNT-PB-200b7 transgenic strains.
Additional Information
How to cite this article: Ye, L. et al. TAL effectors mediate
high-efficiency transposition of the piggyBac transposon in silkwormBombyx mori L. Sci. Rep.
5, 17172; doi: 10.1038/srep17172 (2015).
Authors: T Tamura; C Thibert; C Royer; T Kanda; E Abraham; M Kamba; N Komoto; J L Thomas; B Mauchamp; G Chavancy; P Shirk; M Fraser; J C Prudhomme; P Couble; T Toshiki; T Chantal; R Corinne; K Toshio; A Eappen; K Mari; K Natuo; T Jean-Luc; M Bernard; C Gérard; S Paul; F Malcolm; P Jean-Claude; C Pierre Journal: Nat Biotechnol Date: 2000-01 Impact factor: 54.908
Authors: Andrew J Wood; Te-Wen Lo; Bryan Zeitler; Catherine S Pickle; Edward J Ralston; Andrew H Lee; Rainier Amora; Jeffrey C Miller; Elo Leung; Xiangdong Meng; Lei Zhang; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Barbara J Meyer Journal: Science Date: 2011-06-23 Impact factor: 47.728
Authors: Jeffrey C Miller; Siyuan Tan; Guijuan Qiao; Kyle A Barlow; Jianbin Wang; Danny F Xia; Xiangdong Meng; David E Paschon; Elo Leung; Sarah J Hinkley; Gladys P Dulay; Kevin L Hua; Irina Ankoudinova; Gregory J Cost; Fyodor D Urnov; H Steve Zhang; Michael C Holmes; Lei Zhang; Philip D Gregory; Edward J Rebar Journal: Nat Biotechnol Date: 2010-12-22 Impact factor: 54.908
Authors: Tomas Cermak; Erin L Doyle; Michelle Christian; Li Wang; Yong Zhang; Clarice Schmidt; Joshua A Baller; Nikunj V Somia; Adam J Bogdanove; Daniel F Voytas Journal: Nucleic Acids Res Date: 2011-04-14 Impact factor: 16.971
Authors: Wentian Luo; Daniel L Galvan; Lauren E Woodard; Dan Dorset; Shawn Levy; Matthew H Wilson Journal: Nucleic Acids Res Date: 2017-08-21 Impact factor: 16.971